Erik van Werkhoven

Erasmus University Rotterdam

Netherlands

Research Interests

Explore related searches

Professors in Netherlands Professors in Cancer Research Cancer Research professors in Netherlands

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (5)

Maarit Bärlund

University of Tampere

FINLAND

View details

Joost Vermaat

Leiden University Medical Center

NETHERLANDS

View details

Kenneth G. A. Gilhuijs

NETHERLANDS

View details

Bauke Ylstra

NETHERLANDS

View details

Marije Jacolien Hoornweg

plastic reconstructive surgeon, head of the department

Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital

NETHERLANDS

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Erik van Werkhoven

Research Interests

Explore related searches

Contact this professor

Articles (10)

High-dose alkylating chemotherapy in BRCA-altered triple-negative breast cancer: the randomized phase III NeoTN trial

A non-randomized risk-adjusted comparison of lenalidomide + R-CHOP versus R-CHOP for MYC-rearranged DLBCL patients

Immediate or delayed oncoplastic surgery after breast conserving surgery at the Netherlands Cancer Institute

Patterns of Recurrence and Survival After Pelvic Treatment for Locally Advanced Penile Cancer

Continuation of fluoropyrimidine treatment with S-1 after cardiotoxicity on capecitabine- or 5-fluorouracil-based therapy in patients with solid tumours

Sex differences in patients with gastrointestinal stromal tumours

The influence of docetaxel schedule on treatment tolerability and efficacy in patients with metastatic breast cancer

Predictive value of chromosome 18q11.2-q12.1 loss for benefit from bevacizumab in metastatic colorectal cancer

Efficacy of neoadjuvant treatment with or without pertuzumab in patients with stage II and III HER2-positive breast cancer: a nationwide cohort analysis of pathologic response and 5-year survival

Trastuzumab and pertuzumab combination therapy for advanced pre-treated HER2 exon 20-mutated non-small cell lung cancer

Collaborators (5)

Maarit Bärlund

Joost Vermaat

Kenneth G. A. Gilhuijs

Bauke Ylstra

Marije Jacolien Hoornweg

Make your next move.